137 related articles for article (PubMed ID: 15065858)
1. Thrombin activity is unaltered by N-terminal truncation of factor XIII activation peptides.
Isetti G; Maurer MC
Biochemistry; 2004 Apr; 43(14):4150-9. PubMed ID: 15065858
[TBL] [Abstract][Full Text] [Related]
2. Examining thrombin hydrolysis of the factor XIII activation peptide segment leads to a proposal for explaining the cardioprotective effects observed with the factor XIII V34L mutation.
Trumbo TA; Maurer MC
J Biol Chem; 2000 Jul; 275(27):20627-31. PubMed ID: 10801785
[TBL] [Abstract][Full Text] [Related]
3. Structural examination of the influence of phosphorylation on the binding of fibrinopeptide A to bovine thrombin.
Maurer MC; Peng JL; An SS; Trosset JY; Henschen-Edman A; Scheraga HA
Biochemistry; 1998 Apr; 37(17):5888-902. PubMed ID: 9558322
[TBL] [Abstract][Full Text] [Related]
4. Analysis of factor XIII substrate specificity using recombinant human factor XIII and tissue transglutaminase chimeras.
Hettasch JM; Peoples KA; Greenberg CS
J Biol Chem; 1997 Oct; 272(40):25149-56. PubMed ID: 9312126
[TBL] [Abstract][Full Text] [Related]
5. Identification of Factor XIII β-Sandwich Residues Mediating Glutamine Substrate Binding and Activation Peptide Cleavage.
Mohammed RDS; Piell KM; Maurer MC
Thromb Haemost; 2024 May; 124(5):408-422. PubMed ID: 38040030
[TBL] [Abstract][Full Text] [Related]
6. Plasmin desensitization of the PAR1 thrombin receptor: kinetics, sites of truncation, and implications for thrombolytic therapy.
Kuliopulos A; Covic L; Seeley SK; Sheridan PJ; Helin J; Costello CE
Biochemistry; 1999 Apr; 38(14):4572-85. PubMed ID: 10194379
[TBL] [Abstract][Full Text] [Related]
7. Crosslinking kinetics of the human transglutaminase, factor XIII[A2], acting on fibrin gels and gamma-chain peptides.
Lewis KB; Teller DC; Fry J; Lasser GW; Bishop PD
Biochemistry; 1997 Feb; 36(5):995-1002. PubMed ID: 9033388
[TBL] [Abstract][Full Text] [Related]
8. Human cytomegalovirus protease complexes its substrate recognition sequences in an extended peptide conformation.
LaPlante SR; Aubry N; Bonneau PR; Cameron DR; Lagacé L; Massariol MJ; Montpetit H; Plouffe C; Kawai SH; Fulton BD; Chen Z; Ni F
Biochemistry; 1998 Jul; 37(27):9793-801. PubMed ID: 9657693
[TBL] [Abstract][Full Text] [Related]
9. The ornithodorin-thrombin crystal structure, a key to the TAP enigma?
van de Locht A; Stubbs MT; Bode W; Friedrich T; Bollschweiler C; Höffken W; Huber R
EMBO J; 1996 Nov; 15(22):6011-7. PubMed ID: 8947023
[TBL] [Abstract][Full Text] [Related]
10. The factor XIII V34L polymorphism accelerates thrombin activation of factor XIII and affects cross-linked fibrin structure.
Ariëns RA; Philippou H; Nagaswami C; Weisel JW; Lane DA; Grant PJ
Blood; 2000 Aug; 96(3):988-95. PubMed ID: 10910914
[TBL] [Abstract][Full Text] [Related]
11. Novel aspects of blood coagulation factor XIII. I. Structure, distribution, activation, and function.
Muszbek L; Adány R; Mikkola H
Crit Rev Clin Lab Sci; 1996; 33(5):357-421. PubMed ID: 8922891
[TBL] [Abstract][Full Text] [Related]
12. Thrombin-bound structures of designed analogs of human fibrinopeptide A determined by quantitative transferred NOE spectroscopy: a new structural basis for thrombin specificity.
Ni F; Zhu Y; Scheraga HA
J Mol Biol; 1995 Oct; 252(5):656-71. PubMed ID: 7563081
[TBL] [Abstract][Full Text] [Related]
13. Structural resiliency of an EGF-like subdomain bound to its target protein, thrombin.
Hrabal R; Komives EA; Ni F
Protein Sci; 1996 Feb; 5(2):195-203. PubMed ID: 8745396
[TBL] [Abstract][Full Text] [Related]
14. On the activation of bovine plasma factor XIII. Amino acid sequence of the peptide released by thrombin and the terminal residues of the subunit polypeptides.
Nakamura S; Iwanaga S; Suzuki T
J Biochem; 1975 Dec; 78(6):1247-66. PubMed ID: 1225922
[TBL] [Abstract][Full Text] [Related]
15. Val34Leu polymorphism of plasma factor XIII: biochemistry and epidemiology in familial thrombophilia.
Balogh I; Szôke G; Kárpáti L; Wartiovaara U; Katona E; Komáromi I; Haramura G; Pfliegler G; Mikkola H; Muszbek L
Blood; 2000 Oct; 96(7):2479-86. PubMed ID: 11001900
[TBL] [Abstract][Full Text] [Related]
16. Thrombin-bound conformation of a cyclic anticoagulant peptide using transferred nuclear Overhauser effect (NOE), distance geometry, and NOE simulations.
Ning Q; Ripoll DR; Szewczuk Z; Konishi Y; Ni F
Biopolymers; 1994 Sep; 34(9):1125-37. PubMed ID: 7948726
[TBL] [Abstract][Full Text] [Related]
17. Characterization of the kinetic pathway for fibrin promotion of alpha-thrombin-catalyzed activation of plasma factor XIII.
Naski MC; Lorand L; Shafer JA
Biochemistry; 1991 Jan; 30(4):934-41. PubMed ID: 1989686
[TBL] [Abstract][Full Text] [Related]
18. [Activation of factor XIII by beta-thrombin].
Umarova BA; Strukova SM
Biokhimiia; 1979 Aug; 44(8):1524-9. PubMed ID: 497297
[TBL] [Abstract][Full Text] [Related]
19. Bovine thrombin complexed with an uncleavable analog of residues 7-19 of fibrinogen A alpha: geometry of the catalytic triad and interactions of the P1', P2', and P3' substrate residues.
Martin PD; Malkowski MG; DiMaio J; Konishi Y; Ni F; Edwards BF
Biochemistry; 1996 Oct; 35(40):13030-9. PubMed ID: 8855938
[TBL] [Abstract][Full Text] [Related]
20. Hirunorms are true hirudin mimetics. The crystal structure of human alpha-thrombin-hirunorm V complex.
De Simone G; Lombardi A; Galdiero S; Nastri F; Della Morte R; Staiano N; Pedone C; Bolognesi M; Pavone V
Protein Sci; 1998 Feb; 7(2):243-53. PubMed ID: 9521099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
